Private equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.
Private equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.PEP and Carlyle bought iNova in 2017 from US giant Valeant Pharmaceuticals.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Sources said TPG had emerged from the auction as the most likely buyer after owners Pacific Equity Partners and The Carlyle Group took binding bids on Friday.
The business is expected to be worth more than $2 billion.TPG Capital was one of three known bidders – the others were its global PE rivals Blackstone and Bain Capital.
Sources said the talks to sign a deal were well advanced on Tuesday morning.
Source: Headtopics
Can’t stop reading? Read more
Carlyle and Goldman Sachs open private credit funds to Willow users with $10,000 minimum
Carlyle and Goldman Sachs open private credit funds to Willow users with $10,000 minimum Carlyle,...
EQT, PAI, and Stone Point shortlisted for €2bn takeover of Castik-backed Global Group
EQT, PAI, and Stone Point shortlisted for €2bn takeover of Castik-backed Global Group EQT, PAI...
CAIS Advisors unveils retail vehicle giving investors a stake in elite sports and media
CAIS Advisors unveils retail vehicle giving investors a stake in elite sports and media Eldridge...